What Caught Our Attention in the Investment World? – Week of September 6-9, 2022
By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …
Continue reading “What Caught Our Attention in the Investment World? – Week of September 6-9, 2022”